Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Sanofi Consumer Healthcare India Limited ( (IN:SANOFICONR) ).
Sanofi Consumer Healthcare India Limited’s board has approved the audited standalone financial statements for the quarter and year ended 31 December 2025, along with an unmodified auditors’ report, and will publish the results in newspapers and on its website in line with SEBI requirements. The board has also recommended a final dividend of Rs 75 per equity share for FY 2025, subject to shareholder approval at the upcoming AGM, and reappointed Kishore Bhatia & Associates as cost auditor for the financial year ending 31 December 2026, underscoring continuity in its financial oversight and shareholder-return policies.
More about Sanofi Consumer Healthcare India Limited
Sanofi Consumer Healthcare India Limited operates in the consumer healthcare and over-the-counter pharmaceuticals sector, focusing on health and wellness products for the Indian market. The company is listed on Indian stock exchanges and complies with SEBI’s listing and disclosure regulations as part of its governance and reporting framework.
Average Trading Volume: 414
Technical Sentiment Signal: Sell
Current Market Cap: 92.11B INR
Learn more about SANOFICONR stock on TipRanks’ Stock Analysis page.